HIT Consultant

JULY 26, 2022

What You Should Know: – Exo , a health information and devices company, today has announced it has acquired Medo, an FDA-cleared AI platform that makes ultrasound workflow faster, more reliable, and accessible to all. .

Medical Personnel 98

Medical Personnel FDA 98

HIT Consultant

MARCH 7, 2022

Earlier last year, the FDA issued an emergency use authorization (EUA) for monoclonal antibody treatments bringing additional needs for infusion treatments in many alternate care settings. Similar to 2020, there were increases in demand in 2021 for infusion pumps to treat COVID-19 patients. New Infusion Data Will Optimize Care.

COVID-19 98

COVID-19 FDA Medical Personnel Hospitals 98

HIPAA Journal

APRIL 5, 2023

To the Federal Drug Administration to report adverse events and track FDA-regulated products. For example, in Georgia, medical professionals are required by OCGA §31-7-9 to report any non-accidental patient injuries. To personal representatives of adult patients and unemancipated minor patients.

HIPAA 72

HIPAA Hospitals Compliance Medical Personnel 72

Hall Render

DECEMBER 22, 2023

Accused Of Filing False Claims Settles For $14.7M governor pushes new Medicaid expansion proposal with work requirement Missouri state senator wants voters to have say in KU Health System, Liberty Hospital merger Kansas ACLU request to halt excessive wait times at Larned turned down by judge ‘Who cares about us?

Nursing Homes 40

Nursing Homes Nurses Hospitals COVID-19 40

Hall Render

JANUARY 7, 2022

FDA expands use of Pfizer vaccine, green-lights boosters for children 12-15. HHS: Protections against surprise medical bills implemented at dawn of new year. More Military Medical Personnel Are Assisting Hospitals With Covid-19 Treatment As Staff Shortages Mount. COVID-19 hospitalizations up in 34 states.

COVID-19 40

COVID-19 Nursing Homes US Department of Health and Human Services Nurses 40

Drug & Device Law

MAY 19, 2023

The core premise of Bexis’ article is very simple: Once the FDA has said “yes” and approved a particular drug for a particular indication (“intended use”) for sale in the United States, federal preemption precludes any state from saying say “no” and trying to ban that same FDA-approved drug. T]he growing market for mifepristone. . .

FDA 111

FDA Medical Personnel Telemedicine Licensing 111

Drug & Device Law

JUNE 6, 2022

The prescriber] provided explicit, uncontroverted testimony that, even when provided with the most current research and FDA mandated warnings, as well as the information found in [defendant’s] updated. . . 2001) (no causation where medical personnel “had no alternative other than to use the. . . 3d 1223, 1233 (11th Cir.

FDA 59

FDA Doctors Malpractice Medical Personnel 59